 RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 GLOBE NEWSWIRE -- ADMA Biologics, Inc. NASDAQ: ADMA ADMA, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the commencement of operations and initiation of donor plasma collections at its newest ADMA BioCenters plasma collection facility located in Conyers, Georgia. In conjunction with the plasma collection center opening, ADMA also announced the implementation of the Haemonetics Persona Plasma Collection Solution for the NexSys PCS system Persona across its plasma collection center network. 